Le Lézard
Classified in: Health
Subjects: PER, MAT, SHM


CALGARY, AB, June 23, 2022 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB.V) a premium vertically integrated Canadian cannabis company, is pleased to report that at our Annual & Special Meeting (the "Meeting") held on June 23, 2022, all resolutions proposed to shareholders were duly passed.

Shareholders approved the re-election of all individuals to the Board of Directors of the Company, being Travis McIntyre, Gregory Smith, Donald Cowie, Alex Michaud, Barbara O'Neill and Shane Chana. In addition, shareholders also approved fixing the number of directors at six, the appointment of BDO Canada LLP as Auditors, the ratification of the amended stock option plan and a resolution giving management the discretion to change the Company's name at some point in the future from "Canadabis Capital Inc." to "Stigma Cannabis Inc." should such a change offer strategic benefit for CanadaBis.

"I am very pleased to be joined by such a skilled and dedicated group of individuals on our Board of Directors as we move into the next stages of our corporate evolution, which may include a name change in the future to Stigma Cannabis should management determine a rebrand offers incremental strategic benefit," said Travis McIntyre, President and Director of CanadaBis. "We are grateful to have our Board's wealth of experience, which collectively spans over 100 years across diverse leadership roles, which will continue to be invaluable as we navigate our growth trajectory."


CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth, from cultivation to retail, within the rapidly-emerging global cannabis market. 100% owned subsidiary, Stigma Grow (www.stigmagrow.ca) (1998643 Alberta Ltd.), is a cutting-edge cannabis cultivation and extraction company positioned advantageously to meet the unmet market demands and address legal cannabis industry stigmas head on, with products designed to disrupt the status quo and dramatically shift the conversation surrounding Canada's legal cannabis industry. Other 100% held entities include Stigma Pharmaceuticals Inc.; Stigma Roots (Full Spectrum Labs Ltd.) and INDICAtive Collection (www.indicativecollection.ca) (2103157 Alberta Ltd.), along with our 95% held subsidiary, Goldstream Cannabis Inc.  By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on potential expansion areas and avenues for continued diversification while continuing to prioritize becoming leaders in our industry.



This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to our business and operations; timing of the Company's profitability; the demand and sales volumes of the Company's products, and our general business plans. Forward-looking statements are necessarily based upon a number of assumptions including: the ability of the Company's products to compete with the pricing and product availability on the black-market; the market demand for the Company's products; and assumptions concerning the Company's competitive advantages. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; ability to sustain or create demand for a product; requirement for further capital; delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Company's continuous disclosure on SEDAR at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.

Accordingly, readers should not place undue reliance on forward-looking statements. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although we believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have a material adverse effect on our future results, performance or achievements.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE CanadaBis Capital Inc.

These press releases may also interest you

at 12:45
The "Global 3D Bioprinting Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Component, Material, Application, and Region" report has been added to  ResearchAndMarkets.com's offering. According to this analysis, the Global 3D...

at 12:40
It is with great sadness that Welltower acknowledges the passing of its former chief executive officer and chairman, George L. Chapman. Mr. Chapman was a trailblazer in the seniors housing industry, joining the first health care real estate...

at 12:30
The "Clinical Trials Outsourcing Market Share, Size, Trends, Industry Analysis Report, By End-Use, By Therapeutics Area, By Workflow, By Region, Segment Forecast, 2022 - 2030" report has been added to  ResearchAndMarkets.com's offering. The global...

at 12:30
The empty capsules industry is expected to experience steady growth in the near future. This is due to the increased demand for empty capsules as a result of the growing popularity of dietary supplements and nutraceuticals. The increasing awareness...

at 12:26
Sunshine Health, the state's largest managed care organization, and Farm Share, the state's largest independent food relief organization, today announced they have expanded their partnership to help fight food insecurity across Florida....

at 12:23
Shanghai Henlius...

News published on 23 june 2022 at 17:30 and distributed by: